A detailed history of Institute For Wealth Management, Llc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Institute For Wealth Management, Llc. holds 3,586 shares of VRTX stock, worth $1.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,586
Previous 3,564 0.62%
Holding current value
$1.8 Million
Previous $1.49 Million 12.83%
% of portfolio
0.23%
Previous 0.19%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$392.81 - $485.53 $8,641 - $10,681
22 Added 0.62%
3,586 $1.68 Million
Q4 2023

Jan 31, 2024

SELL
$343.0 - $410.68 $1,372 - $1,642
-4 Reduced 0.11%
3,564 $1.45 Million
Q3 2023

Oct 13, 2023

SELL
$338.18 - $362.46 $3,043 - $3,262
-9 Reduced 0.25%
3,568 $1.24 Million
Q2 2023

Jul 25, 2023

SELL
$314.42 - $351.91 $15,092 - $16,891
-48 Reduced 1.32%
3,577 $1.26 Million
Q4 2022

Feb 02, 2023

SELL
$285.76 - $321.48 $11,144 - $12,537
-39 Reduced 1.06%
3,625 $1.05 Million
Q1 2022

Apr 29, 2022

SELL
$221.42 - $260.97 $13,063 - $15,397
-59 Reduced 1.58%
3,664 $956,000
Q4 2021

Jan 21, 2022

SELL
$177.01 - $223.45 $1,947 - $2,457
-11 Reduced 0.29%
3,723 $818,000
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $4,534 - $5,074
-25 Reduced 0.67%
3,734 $677,000
Q2 2021

Jul 21, 2021

SELL
$187.49 - $221.1 $10,311 - $12,160
-55 Reduced 1.44%
3,759 $758,000
Q1 2021

May 04, 2021

BUY
$207.02 - $241.31 $29,810 - $34,748
144 Added 3.92%
3,814 $820,000
Q4 2020

Feb 01, 2021

SELL
$207.01 - $276.09 $16,974 - $22,639
-82 Reduced 2.19%
3,670 $867,000
Q3 2020

Nov 03, 2020

SELL
$255.65 - $303.1 $7,158 - $8,486
-28 Reduced 0.74%
3,752 $1.02 Million
Q2 2020

Jul 30, 2020

SELL
$225.48 - $295.8 $20,518 - $26,917
-91 Reduced 2.35%
3,780 $1.1 Million
Q1 2020

Apr 29, 2020

SELL
$199.77 - $247.81 $149,627 - $185,609
-749 Reduced 16.21%
3,871 $921,000
Q4 2019

Feb 27, 2020

BUY
$166.71 - $223.91 $601,656 - $808,091
3,609 Added 356.97%
4,620 $1.01 Million
Q4 2019

Jan 27, 2020

SELL
$166.71 - $223.91 $607,491 - $815,928
-3,644 Reduced 78.28%
1,011 $1.01 Million
Q3 2019

Oct 28, 2019

SELL
$166.23 - $187.09 $4,321 - $4,864
-26 Reduced 0.56%
4,655 $789,000
Q2 2019

Aug 02, 2019

SELL
$164.61 - $190.37 $43,950 - $50,828
-267 Reduced 5.4%
4,681 $858,000
Q1 2019

May 15, 2019

SELL
$163.73 - $194.7 $6,549 - $7,788
-40 Reduced 0.8%
4,948 $910,000
Q4 2018

Feb 08, 2019

BUY
$151.91 - $192.21 $757,727 - $958,743
4,988 New
4,988 $826,000
Q1 2018

May 15, 2018

SELL
$151.6 - $177.13 $752,845 - $879,627
-4,966 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$137.28 - $155.55 $681,732 - $772,461
4,966 New
4,966 $743,000
Q3 2017

Nov 14, 2017

SELL
$148.13 - $162.24 $799,013 - $875,122
-5,394 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
5,394
5,394 $694,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Institute For Wealth Management, Llc. Portfolio

Follow Institute For Wealth Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institute For Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Institute For Wealth Management, Llc. with notifications on news.